This webinar provides an introduction to the stages of this process from discovery to clinical trials and pharmaceutical development.

This webinar focused on the particular challenges regarding progressing antibacterial drug discovery projects for small and medium-sized enterprises (SMEs) and their potential solutions.

This session covered the full antimicrobial development journey from discovery to Phase 1, detailing strategies for hit-to-lead and preclinical candidate selection (Alita Miller) and outlining non-clinical, regulatory, and CMC requirements for first-in-human studies (Patricia Bradford).

This session examined Go/No-Go decision-making in antibacterial drug discovery from both industry and academic perspectives, emphasizing the role of TPPs and TCPs in guiding preclinical progression and highlighting how structured support like ENABLE helps translate academic findings into viable drug candidates.

This webinar recording showcases expert-led success stories and scientific advances in novel antibiotics, including breakthroughs against multidrug-resistant Gram-negative bacteria and the development of endolysins through to human trials.